The Pitfall of Ganglioneuroblastoma-Nodular Diagnosis: Clinical and Imaging Considerations over a Rare Bifocal Sporadic Case
Authors:
- Claudio MontanteCMClaudio Montante
- Francesco FabozziFFFrancesco Fabozzi
- Maria Felicia VillaniMVMaria Felicia Villani
- Maria Luisa D’andreaMDMaria Luisa D’andrea
- Alessandra StracuzziASAlessandra Stracuzzi
- Gian Luigi NataliGNGian Luigi Natali
- Giada Del BaldoGBGiada Del Baldo
- Francesca Del BufaloFBFrancesca Del Bufalo
- Maria Carmen GarganeseMGMaria Carmen Garganese
- Annalisa SerraASAnnalisa Serra
- Paolo TomàPTPaolo Tomà
- Rita AlaggioRARita Alaggio
Open Access
- 19 December 2022
- journal article
- editorial
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3221
Abstract
Neuroblastic tumors (NTs) represent the most common extracranial neoplasm occurring in childhood. Although ganglioneuroblastoma intermixed (GNBI) and ganglioneuroma (GN) are classified as very low-risk tumors, neuroblastoma (NB) and ganglioneuroblastoma-nodular (GNBN) may represent a serious risk to survival. Unfortunately, areas of GNBI and GNBN can coexist in the same mass, leading to incorrect risk staging when only biopsy is performed. Herein, we describe a case of multifocal NT (thoracic and abdominal localization) occurring in a 4-year-old male. Different histological subtypes, namely GNBI and GNBN, were revealed in the two lesions. We focus on the difficulties of proper diagnosis and risk stratification, underlining the usefulness of several diagnostic tools for appropriate management and therapeutic choices.Keywords
This publication has 17 references indexed in Scilit:
- Paediatric nuclear medicine imagingBritish Medical Bulletin, 2017
- Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixedPediatric Surgery International, 2017
- Role of diffusion‐weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation gradesJournal of Medical Imaging and Radiation Oncology, 2017
- Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine TumoursEndocrine Pathology, 2017
- Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixedBMC Cancer, 2016
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of ageEuropean Journal of Cancer, 2006
- Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of PatientsJournal of Clinical Oncology, 2001
- The International Neuroblastoma Pathology Classification (the Shimada system)Cancer, 1999
- Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc AnalysisJNCI: Journal of the National Cancer Institute, 1995